Stockscreener 앱 받기
49.96
2.99%
1.45
전일 마감가:
$48.51
열려 있는:
$48
하루 거래량:
1.28M
Relative Volume:
1.39
시가총액:
$2.76B
수익:
$249.12M
순이익/손실:
$-90.19M
주가수익비율:
-29.39
EPS:
-1.7
순현금흐름:
$-88.21M
1주 성능:
-10.34%
1개월 성능:
-11.68%
6개월 성능:
-31.09%
1년 성능:
-19.42%
1일 변동 폭
$47.13
$49.99
1주일 범위
$47.13
$56.87
52주 변동 폭
$47.04
$103.81
Procept Biorobotics Corp Stock (PRCT) Company Profile
명칭
Procept Biorobotics Corp
전화
(650) 232-9832
주소
150 BAYTECH DRIVE, SAN JOSE
PRCT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
49.96 | 2.68B | 249.12M | -90.19M | -88.21M | -1.70 |
|
ABT
Abbott Laboratories
|
127.29 | 219.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.41 | 155.22B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
377.79 | 150.09B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.34 | 115.62B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.33 | 46.52B | 5.69B | 4.15B | 623.10M | 6.95 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-09 | 개시 | Stephens | Overweight |
| 2025-07-07 | 개시 | Oppenheimer | Perform |
| 2024-12-02 | 개시 | Morgan Stanley | Overweight |
| 2024-11-14 | 개시 | Jefferies | Hold |
| 2023-08-11 | 개시 | Piper Sandler | Overweight |
| 2023-05-31 | 개시 | William Blair | Outperform |
| 2022-10-31 | 개시 | BTIG Research | Neutral |
| 2022-10-25 | 개시 | Truist | Buy |
| 2022-09-02 | 개시 | Wells Fargo | Overweight |
| 2022-07-15 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | 개시 | B. Riley Securities | Buy |
| 2021-10-11 | 개시 | BofA Securities | Buy |
| 2021-10-11 | 개시 | Cowen | Outperform |
| 2021-10-11 | 개시 | Goldman | Neutral |
| 2021-10-11 | 개시 | Guggenheim | Buy |
| 2021-10-11 | 개시 | SVB Leerink | Outperform |
모두보기
Procept Biorobotics Corp 주식(PRCT)의 최신 뉴스
Quant Funds Rotate Into PROCEPT BioRobotics Corporation StockTechnical Entry Strategy for Beginners Explained - metal.it
Market reaction to PROCEPT BioRobotics Corporation’s recent newsSmart Allocation Stock Pick Insights Gaining Interest - metal.it
When is PROCEPT BioRobotics Corporation stock expected to show significant growthChart Pattern Data Feed For Beginners - jammulinksnews.com
Is it the right time to buy PROCEPT BioRobotics Corporation stockDaily Trading Insights With High Returns - jammulinksnews.com
Is PROCEPT BioRobotics Corporation a growth stock or a value stockAdvanced Screener Growth Plan For Every Investor - jammulinksnews.com
Will PROCEPT BioRobotics Corporation (PRCT) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
Published on: 2025-07-29 00:15:20 - metal.it
Buy Rating Affirmed for PROCEPT BioRobotics Amid Strategic Leadership and Strong Financial Performance - TipRanks
Why is PROCEPT BioRobotics Corporation stock attracting strong analyst attentionCapitalize on market trends with confidence - jammulinksnews.com
How strong is PROCEPT BioRobotics Corporation company’s balance sheetBuild wealth faster with expert stock picks - jammulinksnews.com
Procept BioRobotics down after CEO retirement - MSN
How does PROCEPT BioRobotics Corporation compare to its industry peersFree Investment Timing Strategies - jammulinksnews.com
How does PROCEPT BioRobotics Corporation generate profit in a changing economyAchieve triple-digit returns with smart investing - jammulinksnews.com
What makes PROCEPT BioRobotics Corporation stock price move sharplyFree Stock Selection - metal.it
Why PROCEPT BioRobotics Corporation stock attracts strong analyst attentionLow Risk Consistent Winners - metal.it
Procept BioRobotics' Leadership Transition: A Strategic Inflection Point or a Missed Opportunity? - AInvest
Navigating Leadership Transitions: Assessing the Impact of CEO Change on Procept BioRobotics' Growth Trajectory - AInvest
Procept BioRobotics' CEO Transition: A Catalyst for Short-Term Volatility or Long-Term Value? - AInvest
Procept Biorobotics stock falls after CEO succession announcement By Investing.com - Investing.com India
Procept Biorobotics stock falls after CEO succession announcement - Investing.com Australia
Edwards Exec Larry Wood Departs for Procept BioRobotics - Orange County Business Journal
Procept BioRobotics Plunges 9.6%, What’s Next for This Surgical Robotics Contender? - AInvest
Leadership Change and Revenue Surge Shake PROCEPT BioRobotics - TipRanks
Procept BioRobotics (PRCT) Shares Drop Amid CEO Transition - GuruFocus
Edwards loses longtime TAVR leader Larry Wood - MedTech Dive
Procept BioRobotics stock down on CEO exit (PRCT:NASDAQ) - Seeking Alpha
What analysts say about PROCEPT BioRobotics Corporation stockUnmatched market gains - Autocar Professional
Procept BioRobotics CEO Reza Zadno reitiring, Larry Wood to succeed - MSN
PROCEPT BioRobotics Appoints New CEO Larry L. Wood - TipRanks
Procept Biorobotics CEO to retire, Edwards VP, TAVR head named as successor - MassDevice
Procept Biorobotics Corporation Announces Executive Changes - MarketScreener
Is PROCEPT BioRobotics Corporation stock a growth or value playFree Trend-Following Techniques - jammulinksnews.com
PROCEPT BioRobotics: Promising Growth Under New Leadership and Attractive Valuation - TipRanks
What drove PRCT's earnings growth in 2024? - AInvest
What's the outlook for PRCT's Q1 2025 earnings? - AInvest
Why did PRCT's Q3 earnings exceed forecasts? - AInvest
Larry Wood to join PROCEPT BioRobotics as CEO, company reports 48% revenue growth - Investing.com
Larry Wood to Lead Procept BioRobotics (PRCT) as New CEO | PRCT Stock News - GuruFocus
Procept BioRobotics (PRCT) Exceeds Q2 Revenue Projections | PRCT Stock News - GuruFocus
Larry L. Wood Appointed CEO of PROCEPT BioRobotics; Company Pre-Announces 48% Revenue Growth for 2Q25 - Nasdaq
PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to - GlobeNewswire
PROCEPT BioRobotics Achieves 48% Revenue Surge to $79.2M as Edwards Lifesciences Veteran Takes CEO Role - Stock Titan
Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy - GlobeNewswire
What drives PROCEPT BioRobotics Corporation stock priceRapid-fire capital growth - jammulinksnews.com
Redefining Prostate Cancer Care: How PROCEPT BioRobotics' Aquablation Therapy Could Disrupt Urology and Unlock a $10B+ Market - AInvest
PROCEPT BioRobotics (PRCT) Achieves Milestone in Prostate Cancer Trial | PRCT Stock News - GuruFocus
Procept Biorobotics Corp (PRCT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.21%
0.17%
자본화:
|
볼륨(24시간):